SPRY4 (sprouty RTK signaling antagonist 4)

2007-02-01  

Identity

HGNC
LOCATION
5q31.3
LOCUSID
ALIAS
HH17
FUSION GENES

Other Information

Locus ID:

NCBI: 81848
MIM: 607984
HGNC: 15533
Ensembl: ENSG00000187678

Variants:

dbSNP: 81848
ClinVar: 81848
TCGA: ENSG00000187678
COSMIC: SPRY4

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000187678ENST00000344120A0A0C4DFS6
ENSG00000187678ENST00000434127Q9C004
ENSG00000187678ENST00000511815D6RB56

Expression (GTEx)

0
10
20
30
40
50
60

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
326181532023Sprouty 4 suppresses glioblastoma invasion by inhibiting ERK phosphorylation and ETS-1-induced matrix metalloproteinase-9.2
363843662023Sprouty4 is epigenetically upregulated in human colorectal cancer.3
370425732023PDK1-stabilized LncRNA SPRY4-IT1 promotes breast cancer progression via activating NF-κB signaling pathway.0
326181532023Sprouty 4 suppresses glioblastoma invasion by inhibiting ERK phosphorylation and ETS-1-induced matrix metalloproteinase-9.2
363843662023Sprouty4 is epigenetically upregulated in human colorectal cancer.3
370425732023PDK1-stabilized LncRNA SPRY4-IT1 promotes breast cancer progression via activating NF-κB signaling pathway.0
360824062022SPRY4 promotes adipogenic differentiation of human mesenchymal stem cells through the MEK-ERK1/2 signaling pathway.1
360824062022SPRY4 promotes adipogenic differentiation of human mesenchymal stem cells through the MEK-ERK1/2 signaling pathway.1
323899012021Prevalence and associated phenotypes of DUSP6, IL17RD and SPRY4 variants in a large Chinese cohort with isolated hypogonadotropic hypogonadism.5
336700442021A Sprouty4 Mutation Identified in Kallmann Syndrome Increases the Inhibitory Potency of the Protein towards FGF and Connected Processes.4
337575662021Long non-coding RNA SPRY4-IT1 as a promising indicator for three field lymph-node dissection of thoracic esophageal carcinoma.3
338796352021SPRY4 suppresses proliferation and induces apoptosis of colorectal cancer cells by repressing oncogene EZH2.5
339063932021Identification of SPRY4 as a Novel Candidate Susceptibility Gene for Familial Nonmedullary Thyroid Cancer.9
340484712021Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinoma.1
343398012021Coupling HDAC4 with transcriptional factor MEF2D abrogates SPRY4-mediated suppression of ERK activation and elicits hepatocellular carcinoma drug resistance.8

Citation

Dessen P

SPRY4 (sprouty RTK signaling antagonist 4)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/43800/spry4-(sprouty-rtk-signaling-antagonist-4)